Navigation Links
Horizon Technology Finance Closes $2 Million Venture Loan Facility with New Haven Pharmaceuticals
Date:4/25/2013

FARMINGTON, Conn. and GUILFORD, Conn., April 25, 2013 /PRNewswire/ -- Horizon Technology Finance Corporation (Nasdaq: HRZN) ("Horizon"), a leading specialty finance company that provides secured loans to venture capital and private equity backed development-stage companies in the technology, life science, healthcare information and services, and clean-tech industries, today announced it has closed a $2 million venture loan facility with New Haven Pharmaceuticals, Inc. ("NHP"), a developer of prescription pharmaceuticals that utilize currently marketed drugs or active pharmaceutical ingredients generally recognized as safe for use in therapeutic applications. The proceeds of the venture loan facility will be used for working capital purposes.

"We are pleased to provide NHP with a venture loan facility which will support its development of proprietary prescription pharmaceuticals," stated Gerald A. Michaud , President of Horizon. "NHP continues to achieve important strides in developing products for patients with a higher risk for secondary strokes or acute cardiac events. Based on the company's impressive product pipeline and experienced, well-respected management team, NHP represents a strong addition to Horizon's high-quality investment portfolio."

"Horizon's $2 million venture loan facility provides NHP with the right capital structure and the timely liquidity to continue to execute our product development and FDA registration plans," stated Patrick P. Fourteau, NHP's President & CEO. Harry H. Penner, Jr. , NHP's Executive Chairman, added, "The responsiveness and flexibility of the Horizon team resulted in a seamless process from initial contact to funding and a very positive business experience. It's gratifying to have Horizon, a Conn
'/>"/>

SOURCE Horizon Technology Finance Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Future Horizons in the Global Orthopedics Market
2. Horizon Pharma Announces Issuance of U.S. Patent Covering RAYOS (delayed-release prednisone)
3. 110+ Health Care Providers Announce Plans To Use Advanced Medical Records Technology To Improve Care For Thousands Of Denver-Area Patients
4. Memorial Hospital of Lafayette County Boosts Patient Safety with Expanded Use of Capnography Technology
5. TriMix Laboratories Announces New TriMix-gel Partnership with KRS Global Biotechnology
6. Endexx to attend NAMA Spring Expo for Medical Marijuana Technology Solutions
7. Creabilis Awarded Prestigious European Commission FP7 Grant to Further Develop its LSE Topical-by-Design Technology
8. iBio Passes Commercial Technology Transfer Milestone
9. Sanovas Launches Next Generation Surgical Imaging Technology
10. George Rosenkranz to Receive 2013 Biotechnology Heritage Award
11. Besins Healthcare, Shin Nippon Biomedical Laboratories, Ltd Announce Delivery Technology Licensing Agreement for Intranasal Progesterone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 Pfenex Inc. (NYSE MKT: PFNX) today announced ... of 8,333,333 shares of its common  stock at a price ... common stock was offered by Pfenex. In addition, Pfenex has ... 1,250,000 additional shares of common stock at the initial public ... the NYSE MKT under the symbol "PFNX." ...
(Date:7/29/2014)... ST. PAUL, Minn. , July 29, 2014 /PRNewswire/ ... of medical devices using neuroblocking technology to treat obesity, ... it will host a conference call on Thursday, August ... financial results for the second quarter ended June 30, ... Conference Call Details The second quarter conference ...
(Date:7/29/2014)... Calif., July 29, 2014 Edwards Lifesciences Corporation (NYSE: ... of heart valves and hemodynamic monitoring, today reported net income ... or $5.09 per diluted share, and non-GAAP net income of ... the same period a year earlier was $93.3 million, or ... million, or $0.84 per diluted share.  Net ...
Breaking Medicine Technology:Pfenex Announces Closing of Initial Public Offering 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3Edwards Lifesciences Reports Strong Second Quarter Results 2Edwards Lifesciences Reports Strong Second Quarter Results 3Edwards Lifesciences Reports Strong Second Quarter Results 4Edwards Lifesciences Reports Strong Second Quarter Results 5Edwards Lifesciences Reports Strong Second Quarter Results 6Edwards Lifesciences Reports Strong Second Quarter Results 7Edwards Lifesciences Reports Strong Second Quarter Results 8Edwards Lifesciences Reports Strong Second Quarter Results 9Edwards Lifesciences Reports Strong Second Quarter Results 10Edwards Lifesciences Reports Strong Second Quarter Results 11Edwards Lifesciences Reports Strong Second Quarter Results 12Edwards Lifesciences Reports Strong Second Quarter Results 13Edwards Lifesciences Reports Strong Second Quarter Results 14Edwards Lifesciences Reports Strong Second Quarter Results 15Edwards Lifesciences Reports Strong Second Quarter Results 16Edwards Lifesciences Reports Strong Second Quarter Results 17Edwards Lifesciences Reports Strong Second Quarter Results 18Edwards Lifesciences Reports Strong Second Quarter Results 19Edwards Lifesciences Reports Strong Second Quarter Results 20Edwards Lifesciences Reports Strong Second Quarter Results 21Edwards Lifesciences Reports Strong Second Quarter Results 22Edwards Lifesciences Reports Strong Second Quarter Results 23Edwards Lifesciences Reports Strong Second Quarter Results 24Edwards Lifesciences Reports Strong Second Quarter Results 25
... the Barbara Ann Karmanos Cancer Institute in Detroit ... Cancer Research,s 100th Annual Meeting 2009 that could ... suffer from a more deadly form of acute ... Xie, Ph.D., presented a poster at the conference ...
... 21 ImQuest BioSciences and Arisyn Therapeutics jointly ... the National Institutes of Health to support the ... treatment of hepatitis C virus (HCV) infection. ... mechanism of action of ATI-0810 (Formerly PG301029) and ...
Cached Medicine Technology:Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia 2Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia 3ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent 2
(Date:7/30/2014)... Dennis Thompson HealthDay Reporter ... fruits and vegetables are vital to good health and a ... hit five servings of fruits and vegetables each day, additional ... review suggests. The human body may only be able ... every day, limiting its ability to absorb important nutrients from ...
(Date:7/30/2014)... FL (PRWEB) July 30, 2014 ... doctoral candidate Renee Gordon and biochemistry professor Ngozi ... to conduct research as Fulbright Scholars. The prestigious ... education exchange program that awards grants to students, ... and conduct research abroad. Both Gordon and Ugochukwu ...
(Date:7/30/2014)... BuyCBDOnline.co , the web's leading ... to announce that it is has made available through ... products available for immediate shipping. , "We have to ... stages," site founder Jason Liss says. "For being such ... of unique products that are available or will be ...
(Date:7/30/2014)... July 30, 2014 The Independent ... will be holding 5 free financial workshops in the ... The goal of these workshops is our collective ... heights of financial empowerment. , These workshops were designed ... Kiyosaki, a successful investor, entrepreneur, and bestselling author (Rich ...
(Date:7/30/2014)... 2014 With the accelerated aging ... health expenditure as well as the improved medical ... diagnostic reagent industry has been developing quickly, especially ... 2013, Chinese in vitro diagnostics market size reached ... in vitro diagnostic reagents. , Chinese in ...
Breaking Medicine News(10 mins):Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 2Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 3Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 3Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 2Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 3Health News:The Independent Woman is Coming to the San Francisco Area in August - Women Helping Women Reach Their Financial Goals 2Health News:The Independent Woman is Coming to the San Francisco Area in August - Women Helping Women Reach Their Financial Goals 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 2Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 4
... Cutting out a can per day brought measurable benefits, study ... small reduction per day in sweetened soft drink intake could ... study, researchers found a measurable reduction in blood pressure -- ... 120/80 desired reading, and 1.1 points in diastolic pressure -- ...
... ... ... 2010 -- Prize4Life ( www.prize4life.org ), a nonprofit organization founded to accelerate the discovery of ... gala and charity auction at the Roger Smith Hotel on Thursday, May 27. The auction ...
... ... serving patients, healthcare providers and payers in region. , ... Philadelphia, PA (PRWEB) May 10, ... infusion services company, focused on providing complex pharmaceutical products and clinical services to ...
... ... Gets Improvements in Global Content, Search Algorithms, and Analysis Tools , ... Boston, MA (Vocus) May 24, 2010 ... IP -- the latest version of its online IP sequence search product. , ...
... researchers find , MONDAY, May 24 (HealthDay News) -- ... a choir could be just what the doctor ordered, ... of relaxation commonly associated with choir participation might actually ... disorder, at least in the short-run, study author Christina ...
... ... While Minimizing the Need for Extensive Healing and Recovery Time , ... Los Angeles, Calif. (PRWEB) May 24, ... considering aesthetic procedures is, “How long will it take to heal and recover?” For ...
Cached Medicine News:Health News:Fewer Sugary Drinks, Less High Blood Pressure 2Health News:Fewer Sugary Drinks, Less High Blood Pressure 3Health News:Prize4Life hosts “Art, Life, Spring” gala and auction to support fight against ALS/Lou Gehrig's Disease 2Health News:Prize4Life hosts “Art, Life, Spring” gala and auction to support fight against ALS/Lou Gehrig's Disease 3Health News:Greater Philadelphia Chamber Welcomes Pentec Health, Incorporated as New Member 2Health News:Greater Philadelphia Chamber Welcomes Pentec Health, Incorporated as New Member 3Health News:GenomeQuest Upgrades Online Patent Searching 2Health News:GenomeQuest Upgrades Online Patent Searching 3Health News:Choir Singing May Relieve Irritable Bowel Syndrome 2Health News:New Laser Treatment Offers Revolutionary Response to Aesthetic Procedure Candidates' Number One Concern: Recovery Time 2
Inquire...
Provides maximum comfort upon insertion through ultra-smooth catheter eyelets--formed with advanced ultrasonic technology....
... A fast, reliable and accurate immunoassay for ... plasma. , ,The fully automated Elecsys proBNP ... in symptomatic patients. NT-proBNP levels also indicate ... the assessment of prognosis. In addition, NT-proBNP ...
... Warming Tube is a cost-effective method of ... to your patient. The warming tube is ... OR, Cath. Lab., and Radiology. The CSZ ... to warm patients since it may be ...
Medicine Products: